Your browser doesn't support javascript.
loading
IncobotulinimtoxinA (Xeomin) for the treatment of adductor laryngeal dystonia: A prospective, open-label clinical trial.
Kohli, Nikita; Lerner, Michael; Rashty, Jamie; Kirke, Diana; Stewart, Thomas; Blitzer, Andrew.
Afiliación
  • Kohli N; Department of Surgery, Division of Otolaryngology, Yale University School of Medicine, New Haven, CT, United States of America. Electronic address: n.kohli@yale.edu.
  • Lerner M; Department of Surgery, Division of Otolaryngology, Yale University School of Medicine, New Haven, CT, United States of America.
  • Rashty J; Wayne State University School of Medicine, Detroit, MI, United States of America.
  • Kirke D; Department of Otolaryngology-Head and Neck Surgery, Icahn School of Medicine at Mount Sinai, New York, NY, United States of America.
  • Stewart T; University of Sydney, Sydney, Australia.
  • Blitzer A; New York Center for Voice and Swallowing Disorders, New York, NY, United States of America; Department of Otolaryngology Head & Neck Surgery, Columbia University College of Physicians & Surgeons, New York, NY, United States of America.
Am J Otolaryngol ; 43(6): 103613, 2022.
Article en En | MEDLINE | ID: mdl-36055061
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Toxinas Botulínicas Tipo A / Distonía / Disfonía Tipo de estudio: Observational_studies Límite: Female / Humans Idioma: En Revista: Am J Otolaryngol Año: 2022 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Toxinas Botulínicas Tipo A / Distonía / Disfonía Tipo de estudio: Observational_studies Límite: Female / Humans Idioma: En Revista: Am J Otolaryngol Año: 2022 Tipo del documento: Article Pais de publicación: Estados Unidos